Our Commitment to Our Values with Integrity as Its Core
By Christophe Weber, Representative Director, President & Chief Executive Officer
I cherish our values and best-in-class governance, which together have enabled Takeda to become the global, values-based, R&D-driven biopharmaceutical leader it is today.
Our values (Integrity, Fairness, Honesty, and Perseverance), which we call Takeda-ism, have remained strong and steady since our origin in Japan in 1781. These values ensure that we always do the right thing for Patients, reinforce Trust with society, improve our company Reputation, and develop our Business (in that order). Takeda-ism and our priorities (Patient, Trust, Reputation, and Business) together form the compass that guides our boundless journey towards Better Health and a Brighter Future for people worldwide through leading innovation in medicine.
As we discover and develop life-saving or life-transforming medicines, we take very seriously our responsibility to improve human health for all. Our patients trust us with their health, and so we must act with the Patient and Trust in mind. At Takeda, we strive to live up to – and exceed – those high expectations.
The Takeda Executive Team (TET) consists of an experienced and diverse group of 20 leaders. Each team member brings a unique perspective to the table, with the team – and our company – made stronger by its diversity in terms of gender, experience, geography, and 11 different nationalities. TET members manage and supervise each function of the Takeda Group, including key committees responsible for matters related to general management, products and R&D, and risk management. This diversity of our leadership is a strength that drives our innovation, agility, and connectivity with an ever-evolving society, forging our path toward our company's future success.
Takeda’s Board of Directors holds me accountable for ensuring that all our decisions and actions are in the best interests of all stakeholders and aligned with our values. With 11 of our 16 Board members serving as Independent Directors, we guarantee our independence to represent those stakeholders. Furthermore, members within three key governance committees (i.e. Audit and Supervisory Committee, Compensation Committee, and Nomination Committee) are Independent Directors, including the chair of every committee. Our Board meetings are also chaired by an Independent Director. Our advanced and robust corporate governance model has been, and will continue to be, critical to Takeda's success.
As we are now entering into a new phase of Takeda’s development, our values and heritage inspire us to improve more lives in the future, as a truly global biopharmaceutical leader with an unwavering commitment to patients. For generations to come, our commitment to realizing Better Health and a Brighter Future for all – and doing so with the utmost integrity – will remain steadfast.
Corporate Governance Report (July 16, 2019)